Table 2 Frequency distribution of patient characteristic variables for people initiating daily-dose isoniazid treatment and the proportion of people completing treatment by each characteristic. Treatment completion was categorized as 1) less than 6Â months completed, 2) at least 6Â months but less than 9Â months completed, and 3) 9 or more months completed
|  |  | Distribution | % Achieving Each Level of Isoniazid Treatment Completion | % Completing ≥6 Mo. | |||||
|---|---|---|---|---|---|---|---|---|---|
N | % or Mean of Total | < 6 Months Complete [% or Mean] | ≥6 but < 9 Months Complete [% or Mean] | ≥9 Months Complete [% or Mean] | p-value: 3 Completion Levels | ≥6 Months Complete [% or Mean] | p-value: < 6 vs ≥6 Months Complete | ||
Sex | Female | 575 | 53.6% | 55.8% | 22.1% | 22.1% | 0.232 | 44.2% | 0.158 |
Male | 497 | 46.4% | 51.5% | 25.4% | 23.1% | Â | 48.5% | Â | |
Age Group | 0–14 | 105 | 9.8% | 43.8% | 24.8% | 31.4% | 0.019 | 56.2% | 0.064 |
15–29 | 291 | 27.1% | 58.8% | 23.4% | 17.9% |  | 41.2% |  | |
30–44 | 321 | 29.9% | 53.9% | 25.2% | 20.9% |  | 46.1% |  | |
45–64 | 355 | 33.1% | 52.7% | 22.0% | 25.3% |  | 47.3% |  | |
Census Region | Northeast | 352 | 32.8% | 54.8% | 20.5% | 24.7% | 0.148 | 45.2% | 0.151 |
Midwest | 174 | 16.2% | 52.3% | 25.3% | 22.4% | Â | 47.7% | Â | |
South | 148 | 13.8% | 61.5% | 22.3% | 16.2% | Â | 38.5% | Â | |
West | 398 | 37.1% | 53.8% | 23.6% | 22.6% | Â | 46.2% | Â | |
Patient Location | Large central metro county | 484 | 45.1% | 50.0% | 26.7% | 23.4% | 0.169 | 50.0% | 0.066 |
Large fringe metro county | 413 | 38.5% | 57.6% | 19.6% | 22.8% | Â | 42.4% | Â | |
Any smaller county | 175 | 16.3% | 55.4% | 24.6% | 20.0% | Â | 44.6% | Â | |
% of Households Under FPL in County | < 15% | 596 | 55.6% | 51.7% | 22.8% | 25.5% | 0.035 | 48.3% | 0.115 |
≥15% | 476 | 44.4% | 56.5% | 24.6% | 18.9% |  | 43.5% |  | |
Insurance Type | HMO | 188 | 17.5% | 62.2% | 21.3% | 16.5% | 0.005 | 37.8% | 0.022 |
POS | 742 | 69.2% | 52.8% | 25.1% | 22.1% | Â | 47.2% | Â | |
PPO | 142 | 13.2% | 47.9% | 19.0% | 33.1% | Â | 52.1% | Â | |
INH Days Supply Received on Date of 1st Fill | < 2 month supply | 991 | 92.4% | 54.5% | 24.1% | 21.4% | 0.020 | 45.5% | 0.126 |
≥2 month supply | 81 | 7.6% | 45.7% | 17.3% | 37.0% |  | 54.3% |  | |
Year INH Regimen Started | 2011 Q3–4 | 230 | 21.5% | 58.3% | 23.0% | 18.7% | 0.308 | 41.7% | 0.298 |
2012 Q1–4 | 450 | 42.0% | 54.4% | 21.8% | 23.8% |  | 45.6% |  | |
2013 Q1–4 | 346 | 32.3% | 50.3% | 26.3% | 23.4% |  | 49.7% |  | |
2014Â Q1 | 46 | 4.3% | 52.2% | 23.9% | 23.9% | Â | 47.8% | Â | |
State TB Rate | – |  | 3.85 | 3.84 | 3.81 | 0.846 | 3.83 | 0.864 | |
LTBI Diagnostic Test | TST | 441 | 41.1% | 53.5% | 22.9% | 23.6% | < 0.001 | 46.5% | 0.005 |
IGRA | 219 | 20.4% | 45.2% | 23.7% | 31.1% | Â | 54.8% | Â | |
Unknown/ Other | 412 | 38.4% | 58.7% | 24.3% | 17.0% | Â | 41.3% | Â | |
Percent Foreign Born in County | – |  | 19.96 | 20.24 | 20.97 | 0.403 | 20.60 | 0.516 | |
Count of Clinical Risk Factors | None | 662 | 61.8% | 58.0% | 22.2% | 19.8% | 0.011 | 42.0% | 0.002 |
1 | 304 | 28.4% | 47.7% | 27.0% | 25.3% | Â | 52.3% | Â | |
2 or more | 106 | 9.9% | 45.3% | 22.6% | 32.1% | Â | 54.7% | Â | |
Diagnosis of Contact w/ TBa | No diagnosis | 923 | 86.1% | 54.3% | 23.8% | 21.9% | 0.296 | 45.7% | 0.457 |
Had diagnosis | 149 | 13.9% | 51.0% | 22.2% | 26.9% | Â | 49.0% | Â | |
History of TB/ Late Effects | No diagnosis | 1027 | 95.8% | 54.2% | 23.1% | 22.7% | 0.426 | 45.8% | 0.197 |
Had diagnosis | 45 | 4.2% | 44.4% | 35.6% | 20.0% | Â | 55.6% | Â | |
HIV Positive | No diagnosis | 1030 | 96.1% | 54.7% | 23.4% | 21.9% | 0.004 | 45.3% | 0.007 |
Had diagnosis | 42 | 3.9% | 33.3% | 28.6% | 38.1% | Â | 66.7% | Â | |
Diabetes | No diagnosis | 999 | 93.2% | 54.5% | 23.5% | 22.0% | 0.085 | 45.6% | 0.126 |
Had diagnosis | 73 | 6.8% | 45.2% | 24.7% | 30.1% | Â | 54.8% | Â | |
Tobacco | No diagnosis or medication | 1004 | 93.7% | 54.2% | 23.7% | 22.1% | 0.237 | 45.8% | 0.366 |
Had diagnosis or medication | 68 | 6.3% | 48.5% | 22.1% | 29.4% | Â | 51.5% | Â | |
Immuno-suppressive Medication | No medication | 948 | 88.4% | 55.1% | 23.0% | 21.9% | 0.030 | 44.9% | 0.025 |
Had medication | 124 | 11.6% | 44.4% | 28.2% | 27.4% | Â | 55.6% | Â | |